{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:15:45Z","timestamp":1788880545225,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.kint.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:47:39Z","timestamp":1760694459000},"page":"748-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA \u2265 99.9%"],"prefix":"10.1016","volume":"108","author":[{"given":"Emanuele","family":"Cozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.08.003_bib1","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.08.003_bib2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1681\/ASN.2013070784","article-title":"New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes","volume":"25","author":"Israni","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.08.003_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/TP.0000000000004824","article-title":"Improving the access of highly sensitized patients to kidney transplantation from deceased donors: the Spanish PATHI Program with allocation based on the virtual crossmatch","volume":"108","author":"Valentin","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.08.003_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/TP.0b013e3181b04a5f","article-title":"Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program","volume":"88","author":"Claas","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.08.003_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10511","article-title":"European guideline for the management of kidney transplant patients with HLA antibodies: by the European Society for Organ Transplantation Working Group","volume":"35","author":"Mamode","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.kint.2025.08.003_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2025.100919","article-title":"Spanish guidelines for kidney transplantation in highly sensitized patients with donor-specific anti-HLA antibodies","volume":"39","author":"Mancebo","year":"2025","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.kint.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/TP.0000000000004687","article-title":"Immunized patients face reduced access to transplantation in the Eurotransplant kidney allocation system","volume":"107","author":"de Ferrante","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.08.003_bib8","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.ekir.2024.07.024","article-title":"Imlifidase in highly sensitized kidney transplant recipients with a positive crossmatch against a deceased donor","volume":"9","author":"Kamar","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.08.003_bib9","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.08.003_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15572","article-title":"A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor-specific anti HLA antibodies","volume":"103","author":"Garc\u00eda-Jim\u00e9nez","year":"2024","journal-title":"HLA"},{"key":"10.1016\/j.kint.2025.08.003_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.kint.2025.04.031","article-title":"A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated Panel Reactive Antibody \u2265 99.9%","volume":"108","author":"Cucchiari","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.08.003_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11416","article-title":"Impact of preformed donor-specific anti-HLA-Cw and anti-HLA-DP antibodies on acute antibody-mediated rejection in kidney transplantation","volume":"36","author":"Laboux","year":"2023","journal-title":"Transpl Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825006519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825006519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:19:07Z","timestamp":1760825947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825006519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0085253825006519"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.08.003","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA \u2265 99.9%","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.04.031","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}